Results 61 to 70 of about 6,547,471 (339)
Cryosurgery of hepatic diseases
Бюллетень сибирской медицины, 2006 Literature data are presented on the development of cryosurgery namely cryosurgery of hepatic diseases in Russia. Expe- rience of surgical diseases' clinics of the Siberian State Medical University in which issues of cryosurgery in focal and diffuse ...
B. I. Alperovich
doaj +1 more source
HPV16 E6/E7 -based mRNA vaccine is therapeutic in mice bearing aggressive HPV-positive lesions
Frontiers in Immunology, 2023 HPV (Human papillomavirus) affects 600,000 people worldwide each year. Almost all cervical cancers are associated with a past HPV infection. In particular, the positivity to the high-risk type HPV16 is detected in most of the invasive cervical cancers ...
Kun Zhou +10 more
doaj +1 more source
Metastasis to parotid gland from non Head and Neck tumors [PDF]
, 2018 Most primary tumors spreading metastasis to the parotid gland are usually located in the head and neck region, nonetheless, rarely, parotid gland can also be the target of metastatic localization site of distant primary tumors.
Andrea, Ciorba +9 more
core
FEBS Letters, EarlyView.PARP‐1 is a key enzyme in the DNA damage response, and its inhibition induces cancer cell death via synthetic lethality. Au(I)‐based drugs, such as aurothioglucose and sodium aurothiomalate, block PARP‐1's DNA‐dependent activity by targeting its zinc finger domains.
Uliana Bashtanova, Melinda Jane Duer
wiley +1 more source
Renal papillary carcinoma developed in a kidney transplant recipient with late IgA-nephropathy [PDF]
, 2016 With improvements in immunosuppressive therapy, patient and graft survival in renal transplant recipients have been prolonged. Increasing donor age and patient survival rates have been related to an increase in the number of de novo tumors ...
BERLOCO, Pasquale Bartolomeo +7 more
core +1 more source
Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors.
Cancer Discovery, 2020 Tumor mutational burden (TMB), defined as the number of somatic mutations per megabase of interrogated genomic sequence, varies across malignancies. Panel sequencing-based estimates of TMB have largely replaced whole-exome sequencing-derived TMB in the ...
D. Sha +5 more
semanticscholar +1 more source
Molecular Oncology, EarlyView.Integrating ancestry, differential methylation analysis, and machine learning, we identified robust epigenetic signature genes (ESGs) and Core‐ESGs in Black and White women with endometrial cancer. Core‐ESGs (namely APOBEC1 and PLEKHG5) methylation levels were significantly associated with survival, with tumors from high African ancestry (THA) showing ...
Huma Asif, J. Julie Kim
wiley +1 more source
Molecular Oncology, EarlyView.There is an unmet need in metastatic breast cancer patients to monitor therapy response in real time. In this study, we show how a noninvasive and affordable strategy based on sequencing of plasma samples with longitudinal tracking of tumour fraction paired with a statistical model provides valuable information on treatment response in advance of the ...
Emma J. Beddowes +20 more
wiley +1 more source
Nanostructures as Photothermal Agents in Tumor Treatment [PDF]
, 2022 Yuqian Chen +4 more
openalex +1 more source
Multifocality and recurrence risk: a quantitative model of field cancerization [PDF]
, 2013 Primary tumors often emerge within genetically altered fields of premalignant cells that appear histologically normal but have a high chance of progression to malignancy. Clinical observations have suggested that these premalignant fields pose high risks
Foo, Jasmine, Leder, Kevin, Ryser, Marc
core +1 more source